These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10778490)

  • 1. [Disorders associated with alterations in single peroxisomal proteins, including X-linked adrenoleukodystrophy].
    Moser HW
    Rev Neurol; 1999 Jan; 28 Suppl 1():S55-8. PubMed ID: 10778490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic aspects of X-linked adrenoleukodystrophy.
    Gärtner J; Braun A; Holzinger A; Roerig P; Lenard HG; Roscher AA
    Neuropediatrics; 1998 Feb; 29(1):3-13. PubMed ID: 9553942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of peroxisomal disorders in Japan.
    Suzuki Y; Shimozawa N; Yajima S; Inoue K; Orii T; Kondo N
    Jpn J Hum Genet; 1996 Mar; 41(1):167-75. PubMed ID: 8914632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic strategies for peroxisomal disorders].
    Moser HW
    Rev Neurol; 1999 Jan; 28 Suppl 1():S65-9. PubMed ID: 10778492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Introduction to the study of peroxisomal disorders].
    López-Terradas JM
    Rev Neurol; 1999 Jan; 28 Suppl 1():S34-7. PubMed ID: 10778485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.
    van Geel BM; Assies J; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):4-14. PubMed ID: 9221959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenoleukodystrophy: a fatal disorder with new opportunities for prevention and treatment.
    O'Donnell-O'Toole S
    J Neurosurg Nurs; 1985 Feb; 17(1):53-60. PubMed ID: 3844443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Straight-chain acyl-CoA oxidase knockout mouse accumulates extremely long chain fatty acids from alpha-linolenic acid: evidence for runaway carousel-type enzyme kinetics in peroxisomal beta-oxidation diseases.
    Infante JP; Tschanz CL; Shaw N; Michaud AL; Lawrence P; Brenna JT
    Mol Genet Metab; 2002 Feb; 75(2):108-19. PubMed ID: 11855929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The diagnosis of peroxisomal disorders in Spain during the period 1987-1997].
    Girós M; Ruiz M; Ribes A; Pàmpols T
    Rev Neurol; 1999 Jan; 28 Suppl 1():S40-4. PubMed ID: 10778487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder.
    Dubois-Dalcq M; Feigenbaum V; Aubourg P
    Trends Neurosci; 1999 Jan; 22(1):4-12. PubMed ID: 10088993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisomal disorders: clinical and biochemical studies in 15 children and prenatal diagnosis in 7 families.
    Steinberg SJ; Elçioglu N; Slade CM; Sankaralingam A; Dennis N; Mohammed SN; Fensom AH
    Am J Med Genet; 1999 Aug; 85(5):502-10. PubMed ID: 10405451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apropos of a familial case of adrenoleukodystrophy related to X chromosome diagnosed prenatally].
    Parent P; Le Meur F; Alix D; Le Fur JM; Toudic L; Castel Y
    Pediatrie; 1987; 42(4):297-301. PubMed ID: 3671029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes.
    Mahmood A; Dubey P; Moser HW; Moser A
    Pediatr Transplant; 2005 Dec; 9 Suppl 7():55-62. PubMed ID: 16305618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked adrenoleukodystrophy.
    Moser HW; Mahmood A; Raymond GV
    Nat Clin Pract Neurol; 2007 Mar; 3(3):140-51. PubMed ID: 17342190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical approach to inherited peroxisomal disorders: a series of 27 patients.
    Baumgartner MR; Poll-The BT; Verhoeven NM; Jakobs C; Espeel M; Roels F; Rabier D; Levade T; Rolland MO; Martinez M; Wanders RJ; Saudubray JM
    Ann Neurol; 1998 Nov; 44(5):720-30. PubMed ID: 9818927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel PEX1 mutations and genotype-phenotype correlations in Australasian peroxisome biogenesis disorder patients.
    Maxwell MA; Allen T; Solly PB; Svingen T; Paton BC; Crane DI
    Hum Mutat; 2002 Nov; 20(5):342-51. PubMed ID: 12402331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Our experience in the diagnosis of peroxisomal diseases with an abnormal fatty acid profile].
    López-Pisón J; Pérez-Delgado R; García-Oguiza A; Lafuente-Hidalgo M; García-Jiménez M; Calvo-Ruata ML; Peña-Segura JL; Rebage V; Girós-Blasco M; Coll MJ; Baldellou-Vázquez A
    Rev Neurol; 2008 Jul 1-15; 47(1):1-5. PubMed ID: 18592472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings.
    Hubbard WC; Moser AB; Tortorelli S; Liu A; Jones D; Moser H
    Mol Genet Metab; 2006; 89(1-2):185-7. PubMed ID: 16828324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.